• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助放化疗后食管癌切除术的时机影响吻合口漏的发生率。

Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks.

作者信息

Roh Simon, Iannettoni Mark D, Keech John, Arshava Evgeny V, Swatek Anthony, Zimmerman Miriam B, Weigel Ronald J, Parekh Kalpaj R

机构信息

Division of Interventional Radiology, New York Presbyterian Hospital-Weill Cornell Medical Center.

Department of Cardiovasular Sciences, East Carolina University.

出版信息

Korean J Thorac Cardiovasc Surg. 2019 Feb;52(1):1-8. doi: 10.5090/kjtcs.2019.52.1.1. Epub 2019 Feb 5.

DOI:10.5090/kjtcs.2019.52.1.1
PMID:30834211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6383855/
Abstract

BACKGROUND

Neoadjuvant chemoradiation therapy (nCRT) has become the standard of care for esophageal cancer patients prior to esophagectomy. However, the optimal timing for surgery after completion of nCRT remains unclear.

METHODS

A retrospective review was performed of patients who underwent esophagectomy with cervical anastomosis for esophageal cancer at a single institution between January 2000 and June 2015. Patients were categorized into 3 cohorts: those who did not receive nCRT prior to esophagectomy (no nCRT), those who underwent esophagectomy within 35 days after nCRT (≤35d), and those who underwent esophagectomy more than 35 days after nCRT (>35d).

RESULTS

A total of 366 esophagectomies were performed during the study period, and 348 patients met the inclusion criteria. Anastomotic leaks occurred in 11.8% of all patients included in the study (41 of 348). Within each cohort, anastomotic leaks were detected in 14.7% of patients (17 of 116) in the no nCRT cohort, 7.3% (13 of 177) in the ≤35d cohort, and 20.0% (11 of 55) in the >35d cohort (p=0.020). Significant differences in the occurrence of anastomotic leaks were observed between the no nCRT and ≤35d cohorts (p=0.044), and between the ≤35d and >35d cohorts (p=0.007).

CONCLUSION

Esophagectomy with cervical anastomosis within 35 days of nCRT resulted in a lower percentage of anastomotic leaks.

摘要

背景

新辅助放化疗(nCRT)已成为食管癌患者行食管切除术前的标准治疗方案。然而,nCRT完成后手术的最佳时机仍不明确。

方法

对2000年1月至2015年6月期间在单一机构接受食管癌颈段吻合食管切除术的患者进行回顾性研究。患者分为3组:食管切除术前未接受nCRT的患者(无nCRT组)、nCRT后35天内接受食管切除术的患者(≤35天组)以及nCRT后35天以上接受食管切除术的患者(>35天组)。

结果

研究期间共进行了366例食管切除术,348例患者符合纳入标准。纳入研究的所有患者中吻合口漏发生率为11.8%(348例中的41例)。在每个组中,无nCRT组患者吻合口漏检出率为14.7%(116例中的17例),≤35天组为7.3%(177例中的13例),>35天组为20.0%(55例中的11例)(p = 0.020)。无nCRT组与≤35天组之间(p = 0.044)以及≤35天组与>35天组之间(p = 0.007)吻合口漏发生率存在显著差异。

结论

nCRT后35天内行颈段吻合食管切除术导致吻合口漏的比例较低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/797c/6383855/33e51541ebbc/kjtcv-52-001f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/797c/6383855/33e51541ebbc/kjtcv-52-001f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/797c/6383855/33e51541ebbc/kjtcv-52-001f1.jpg

相似文献

1
Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks.新辅助放化疗后食管癌切除术的时机影响吻合口漏的发生率。
Korean J Thorac Cardiovasc Surg. 2019 Feb;52(1):1-8. doi: 10.5090/kjtcs.2019.52.1.1. Epub 2019 Feb 5.
2
Neoadjuvant chemoradiotherapy may increase the risk of severe anastomotic complications after esophagectomy with cervical anastomosis.新辅助放化疗可能会增加食管切除术后行颈部吻合术发生严重吻合口并发症的风险。
Langenbecks Arch Surg. 2016 May;401(3):323-31. doi: 10.1007/s00423-016-1409-0. Epub 2016 Mar 28.
3
Effect of thoracic versus cervical anastomosis on anastomotic leak among patients who undergo esophagectomy after neoadjuvant chemoradiation.新辅助放化疗后行食管癌切除术患者的胸与颈吻合对吻合口瘘的影响。
J Thorac Cardiovasc Surg. 2020 Oct;160(4):1088-1095. doi: 10.1016/j.jtcvs.2020.01.089. Epub 2020 Feb 20.
4
It's not always too late: a case for minimally invasive salvage esophagectomy.并非总是为时过晚:微创挽救性食管切除术 1 例报告。
Surg Endosc. 2021 Aug;35(8):4700-4711. doi: 10.1007/s00464-020-07937-2. Epub 2020 Sep 17.
5
Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.新辅助放化疗后行食管切除术的时机是否影响疗效?一项荟萃分析。
Int J Surg. 2018 Nov;59:11-18. doi: 10.1016/j.ijsu.2018.09.013. Epub 2018 Sep 24.
6
Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.对于接受新辅助放化疗和经裂孔食管切除术治疗的食管癌患者,辐射剂量并不影响吻合口并发症。
Radiat Oncol. 2015 Mar 6;10:59. doi: 10.1186/s13014-015-0361-4.
7
Clinical utility of robot-assisted transthoracic esophagectomy in advanced esophageal cancer after neoadjuvant chemoradiation therapy.新辅助放化疗后机器人辅助经胸食管癌切除术在晚期食管癌中的临床应用价值
J Thorac Dis. 2019 Jul;11(7):2913-2923. doi: 10.21037/jtd.2019.07.53.
8
Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.增加食管癌新辅助放化疗与手术之间的间隔时间:已发表研究的荟萃分析
Dis Esophagus. 2016 Nov;29(8):1107-1114. doi: 10.1111/dote.12432. Epub 2015 Nov 6.
9
Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy.食管癌根治性放化疗后食管切除术:一种安全的治疗策略。
Dis Esophagus. 2024 Oct 28;37(11). doi: 10.1093/dote/doae059.
10
Radiation to the Gastric Fundus Increases the Risk of Anastomotic Leakage After Esophagectomy.胃底接受放疗会增加食管癌切除术后吻合口漏的风险。
Ann Thorac Surg. 2016 Dec;102(6):1798-1804. doi: 10.1016/j.athoracsur.2016.08.027. Epub 2016 Oct 17.

引用本文的文献

1
Anastomotic Leak After Esophagectomy: Modern Approaches to Prevention and Diagnosis.食管癌切除术后吻合口漏:预防与诊断的现代方法
Cureus. 2025 Mar 5;17(3):e80091. doi: 10.7759/cureus.80091. eCollection 2025 Mar.
2
Timing of Surgery and Postoperative Outcomes in Esophagectomy for Squamous Cell Carcinoma: A Prospective Study in North India.鳞状细胞癌食管癌手术时机与术后结局:印度北部的一项前瞻性研究
J Gastrointest Cancer. 2025 Jan 14;56(1):43. doi: 10.1007/s12029-024-01150-3.
3
The Impact of Diagnostic Laparoscopy on Upstaging Patients with Siewert II and III Gastroesophageal Junction (GEJ) Cancer.

本文引用的文献

1
Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer?延长食管癌新辅助放化疗与食管切除术之间的间隔时间有好处吗?
Ann Thorac Surg. 2016 Aug;102(2):433-8. doi: 10.1016/j.athoracsur.2016.02.058. Epub 2016 May 4.
2
Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.新辅助治疗后远端食管腺癌的食管切除术时机
Ann Thorac Surg. 2016 Mar;101(3):1123-30. doi: 10.1016/j.athoracsur.2015.09.044. Epub 2015 Dec 1.
3
Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.
诊断性腹腔镜检查对Siewert II型和III型胃食管交界(GEJ)癌患者分期上调的影响。
Ann Surg Oncol. 2025 Jan;32(1):258-264. doi: 10.1245/s10434-024-15862-0. Epub 2024 Nov 6.
4
Early thoracic surgery consultation and location of therapy impact time to esophagectomy.早期胸外科会诊及治疗地点会影响食管癌切除术的时间。
J Thorac Dis. 2024 Sep 30;16(9):5615-5623. doi: 10.21037/jtd-24-316. Epub 2024 Sep 21.
5
Surgical intervention after neoadjuvant therapy in esophageal cancer: a narrative review.食管癌新辅助治疗后的手术干预:一项叙述性综述
J Thorac Dis. 2023 Apr 28;15(4):2261-2276. doi: 10.21037/jtd-23-420. Epub 2023 Apr 27.
6
Early versus delayed surgery following neoadjuvant chemoradiation for esophageal cancer: a systematic review and meta-analysis.新辅助放化疗后食管癌的早期与延迟手术:系统评价和荟萃分析。
Esophagus. 2023 Jul;20(3):390-401. doi: 10.1007/s10388-023-00989-y. Epub 2023 Feb 17.
7
Effect of Time to Minimally Invasive Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.新辅助化疗后微创食管切除术治疗食管鳞癌的时间效果。
J Gastrointest Cancer. 2023 Dec;54(4):1240-1251. doi: 10.1007/s12029-023-00915-6. Epub 2023 Feb 1.
8
Anastomotic leakage and postoperative mortality in patients after esophageal cancer resection.食管癌切除术后吻合口漏和术后死亡率。
J Int Med Res. 2021 Sep;49(9):3000605211045540. doi: 10.1177/03000605211045540.
9
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.新辅助放化疗与新辅助化疗治疗食管鳞状细胞癌的比较:来自中国国家癌症中心的一项倾向评分匹配研究
J Cancer Res Clin Oncol. 2022 Apr;148(4):943-954. doi: 10.1007/s00432-021-03659-7. Epub 2021 May 19.
10
Fluorescence Image-Based Evaluation of Gastric Tube Perfusion during Esophagogastrostomy.基于荧光图像的食管胃吻合术中胃管灌注评估
Korean J Thorac Cardiovasc Surg. 2020 Aug 5;53(4):178-183. doi: 10.5090/kjtcs.2020.53.4.178.
从新辅助放化疗到手术的时间增加与食管癌更高的病理完全缓解率相关。
Ann Thorac Surg. 2015 Jan;99(1):270-6. doi: 10.1016/j.athoracsur.2014.08.033. Epub 2014 Nov 18.
4
Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study.新辅助放化疗对食管癌切除术后结局的影响:一项欧洲多中心研究的结果。
Ann Surg. 2014 Nov;260(5):764-70; discussion 770-1. doi: 10.1097/SLA.0000000000000955.
5
Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer.新辅助放化疗对食管癌术后发病率和死亡率的影响。
Dis Esophagus. 2015 May-Jun;28(4):358-64. doi: 10.1111/dote.12207. Epub 2014 Mar 11.
6
Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer?新辅助放化疗后手术时机是否影响食管癌的治疗效果?
Ann Thorac Surg. 2014 Apr;97(4):1181-9. doi: 10.1016/j.athoracsur.2013.12.026. Epub 2014 Feb 14.
7
Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers.可切除食管和胃食管交界处癌症患者接受新辅助化疗或放化疗的术后发病率和围手术期死亡率的荟萃分析。
Br J Surg. 2014 Mar;101(4):321-38. doi: 10.1002/bjs.9418. Epub 2014 Feb 3.
8
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.CROSS 试验中单手术治疗与术前放化疗加手术治疗后的复发模式。
J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13.
9
The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.术前放化疗对进展期食管胃结合部印戒细胞腺癌生存的影响。
Ann Thorac Surg. 2014 Jan;97(1):303-10. doi: 10.1016/j.athoracsur.2013.09.010. Epub 2013 Nov 5.
10
Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.手术前后放化疗治疗局部晚期食管癌:SEER-Medicare 分析。
Ann Surg Oncol. 2013 Nov;20(12):3999-4007. doi: 10.1245/s10434-013-3072-9. Epub 2013 Jun 26.